Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Curing Cold Capsule (Ganmao Jiaonang) is an oral Traditional Chinese Medicine (TCM) formulation manufactured by Jiangxi Hengkang Pharmaceutical. It is an approved over-the-counter (OTC) medication in China, primarily indicated for the treatment of the common cold and the relief of associated symptoms such as fever, headache, cough, and sore throat. The formulation typically consists of herbal ingredients including *Schizonepeta tenuifolia* (spike), *Platycodon grandiflorus*, *Glycyrrhiza uralensis* (licorice), and peppermint oil. These components work synergistically to dispel wind, clear heat, and resolve the exterior, providing antipyretic and anti-inflammatory effects. It is part of Jiangxi Hengkang's commercial portfolio of respiratory treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Curing Cold Capsule.